KAREN JENKINS: Open Payments
NPI 1134714850 · COLONIAL HEIGHTS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 49 payments from 23 companies in 2025. Trend: 2023 $543 · 2024 $754 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $145 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| PFIZER INC. | 6 | $103 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| Actelion Pharmaceuticals US, Inc. | 2 | $62 |
| Lilly USA, LLC | 3 | $57 |
| SCPHARMACEUTICALS INC. | 3 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Novo Nordisk Inc | 2 | $44 |
Products named: REPATHA, LEQVIO, VERQUVO, VYNDAQEL, OPSUMIT, MOUNJARO, FUROSCIX, LifeVest.
Industry payments across VA — which companies pay providers there.
